Zimmer Partners, LP Generation Bio Co. Transaction History
Zimmer Partners, LP
- $4.52 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding GBIO
# of Institutions
82Shares Held
42.4MCall Options Held
70.4KPut Options Held
700-
Price T Rowe Associates Inc Baltimore, MD9.06MShares$3.35 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC8.28MShares$3.06 Million0.97% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$1.22 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY2.97MShares$1.1 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.62MShares$969,2920.0% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $21.8M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...